Metastatic colon adenocarcinoma has a significantly elevated expression of IL-10 compared with primary colon adenocarcinoma tumors

References

• Plewka D, Kowalczyk AE, Jakubiec-Bartnik B, Morek M, Bogunia E, Kmiec A, Wierzbicki PM, Plewka A, Mocellin S, Panelli MC, et al. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Res Vet Sci. 2006;52(5 A):191-7.
   Google Scholar
• Society AC. Colorectal cancer facts & figures 2014–2016. Color Cancer Facts Fig. 2014;1-32.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66(1):7-30. doi:10.3322/caac.21332. PMID:26742998
   PubMed Web of Science ®Google Scholar
• Nowell PC. Linked references are available on JSTOR for this article: The clonal evolution of tumor cell populations. Science. (80-). 1976;194(4260):23-8. doi:10.1126/science.959840. PMID:959840
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-48. doi:10.1016/j.immuni.2004.07.017. PMID:15308095
   PubMed Web of Science ®Google Scholar
• Landskron G, Fuente M De, Thuwajit P, Thuwajit C, Hermoso MA. Review article chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:14918. doi:10.1155/2014/149185. PMID:24901008
   PubMedGoogle Scholar
• Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178:6730-3. doi:10.4049/jimmunol.178.11.6730. PMID:17513719
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7. doi:10.1038/nature01322. PMID:12490959
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904-12. doi:10.1038/onc.2008.271. PMID:18836471
   PubMed Web of Science ®Google Scholar
• Klampfer L. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets. 2011;11(4):451-64. doi:10.2174/156800911795538066. PMID:21247378
   PubMed Web of Science ®Google Scholar
• Lewis AM, Varghese S, Xu H, Alexander HR. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 2006;4(1):48. doi:10.1186/1479-5876-4-48. PMID:17096856
   PubMed Web of Science ®Google Scholar
• Balkwill F. TNF-?? in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409-16. doi:10.1007/s10555-006-9005-3. PMID:16951987
   PubMed Web of Science ®Google Scholar
• Lundholm K, Gelin J, Hyltander A, Lonnroth C, Sandstrom R, Svaninger G, Korner U, Gulich M, Karrefors I, Norli B. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994;54(21):5602-6. PMID:7923204
   PubMed Web of Science ®Google Scholar
• Lebrun J-J. The dual role of TGFβ in human cancer: From tumor suppression to cancer metastasis. ISRN Mol Biol. 2012;2012:381428. doi:10.5402/2012/381428. PMID:27340590
   PubMedGoogle Scholar
• Calon A, Tauriello DVF, Batlle E. TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol. 2014;25:15-22. doi:10.1016/j.semcancer.2013.12.008. PMID:24412104
   PubMed Web of Science ®Google Scholar
• Mantovani A. Cancer: Inflaming metastasis. Nature. 2009;457(7225):36-7. doi:10.1038/457036b. PMID:19122629
   PubMed Web of Science ®Google Scholar
• Rosenblum IY, Dayan AD. Carcinogenicity testing of IL-10: Principles and practicalities. Hum Exp Toxicol. 2002;21(7):347-58. doi:10.1191/0960327102ht275oa. PMID:12269696
   PubMed Web of Science ®Google Scholar
• Kawamura K, Bahar R, Natsume W, Sakiyama S, Tagawa M. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Cancer Gene Ther. 2002;9(1):109-15. doi:10.1038/sj.cgt.7700418. PMID:11916240
   PubMed Web of Science ®Google Scholar
• Kundu N, Fulton AM. Interleukin-10 inhibits tumor metastasis, downregulates MHC Class I, and enhances NK lysis. 1997;61(180):55-61.
   Google Scholar
• Dennis KL, Blatner NR, Gounari F, Khazaie K. Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol. 2013;25(6):637-45. doi:10.1097/CCO.0000000000000006. PMID:24076584
   PubMed Web of Science ®Google Scholar
• Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med. 1998;187(2):177-83. doi:10.1084/jem.187.2.177. PMID:9432975
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin -10 and the I Nterleukin -10 R Eceptor. Annu Rev Immunol. 2001;19(1):683-765. doi:10.1146/annurev.immunol.19.1.683. PMID:11244051
   PubMed Web of Science ®Google Scholar
• Muto G, Kotani H, Kondo T, Morita R, Tsuruta S, Kobayashi T, Luche H, Fehling HJ, Walsh M, Choi Y, et al. TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity. PLoS One. 2013;8(9):1-12. doi:10.1371/journal.pone.0074639
   Web of Science ®Google Scholar
• Caudle AS, Yang WT, Mittendorf EA, Kuerer HM. JAMA surgery. 2016;150(2):137-43.
   Google Scholar
• Badalà F, Nouri-mahdavi K, Raoof DA. NIH Public Access. Computer (Long Beach Calif). 2008;144(5):724-32.
   Google Scholar
• Baglaenko Y, Manion KP, Chang NH, Gracey E, Loh C, Wither JE. IL-10 production is critical for sustaining the expansion of CD5+ B and NKT cells and restraining autoantibody production in congenic lupus-prone mice. PLoS One. 2016;11(3):1-16. doi:10.1371/journal.pone.0150515
   Web of Science ®Google Scholar
• Chen W, Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J Immunol. 1991;147(2):528–534.
   Google Scholar
• Vignot S, Lefebvre C, Frampton GM, Meurice G, Yelensky R, Palmer G, Capron F, Lazar V, Hannoun L, Miller VA, et al. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles. Eur J Cancer. 2015;51(7):791-9. doi:10.1016/j.ejca.2015.02.012. PMID:25797355
   PubMed Web of Science ®Google Scholar